PIR and renal cell adenocarcinoma: By analyzing the expression of piR‐RCC in conjunction with clinical characteristics of RCC patients, we found that piR‐RCC was more down‐regulated in RCC patients with T2‐T4 stage compared to those with T1 stage (Figure 1D).